Comparison of magnetic resonance imaging and ultrasound (MRI-US) fusion-guided prostate biopsies obtained from axial and sagittal approaches

BJU International

Volumn 115, Issue 5, 2015, Pages 772-779

  Hong, Cheng W ^a   Rais Bahrami, Soroush ^b   Walton Diaz, Annerleim ^b   Shakir, Nabeel ^b   Su, Daniel ^a   George, Arvin K ^a   Merino, Maria J ^b   Turkbey, Baris ^b   Choyke, Peter L ^b   Wood, Bradford J ^a   Pinto, Peter A ^a,b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

fusion biopsy; multiparametric MRI; prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGE DISTRIBUTION; ARTICLE; CANCER DIAGNOSIS; CANCER PATIENT; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; DIAGNOSTIC ERROR; GLEASON SCORE; HUMAN; IMAGE GUIDED BIOPSY; IMAGE PROCESSING; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTATE BIOPSY; PROSTATE CANCER; ULTRASOUND; CLINICAL TRIAL; COMPARATIVE STUDY; ECHOGRAPHY; LARGE CORE NEEDLE BIOPSY; PATHOLOGY; PROCEDURES; PROSTATE; PROSTATE TUMOR;

BIOPSY, LARGE-CORE NEEDLE; HUMANS; IMAGE-GUIDED BIOPSY; MAGNETIC RESONANCE IMAGING; MALE; PROSPECTIVE STUDIES; PROSTATE; PROSTATIC NEOPLASMS;

EID: 84927749995     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/bju.12871     Document Type: Article

References (29)

1. Siegel R, Naishadham D, Jemal A,. Cancer statistics, 2013. CA Cancer J Clin 2013; 63: 11-30
2. Raja J, Ramachandran N, Munneke G, Patel U,. Current status of transrectal ultrasound-guided prostate biopsy in the diagnosis of prostate cancer. Clin Radiol 2006; 61: 142-153
3. Patel AR, Jones JS,. Optimal biopsy strategies for the diagnosis and staging of prostate cancer. Curr Opin Urol 2009; 19: 232-237
4. Naughton CK, Miller DC, Yan Y,. Impact of transrectal ultrasound guided prostate biopsy on quality of life: a prospective randomized trial comparing 6 versus 12 cores. J Urol 2001; 165: 100-103
5. Presti JC Jr, O'Dowd GJ, Miller MC, Mattu R, Veltri RW,. Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study. J Urol 2003; 169: 125-129
6. Yacoub JH, Verma S, Moulton JS, Eggener S, Aytekin O,. Imaging-guided prostate biopsy: conventional and emerging techniques. Radiographics 2012; 32: 819-837
7. Turkbey B, Pinto PA, Choyke PL,. Imaging techniques for prostate cancer: implications for focal therapy. Nat Rev Urol 2009; 6: 191-203
8. Turkbey B, Shah VP, Pang Y, et-al. Is apparent diffusion coefficient associated with clinical risk scores for prostate cancers that are visible on 3-T MR images? Radiology 2011; 258: 488-495
9. Rastinehad AR, Baccala AA Jr, Chung PH, et-al. D'Amico risk stratification correlates with degree of suspicion of prostate cancer on multiparametric magnetic resonance imaging. J Urol 2011; 185: 815-820
10. Rais-Bahrami S, Siddiqui MM, Turkbey B, et-al. Utility of multiparametric magnetic resonance imaging suspicion levels for detecting prostate cancer. J Urol 2013; 190: 1721-1727
11. Beyersdorff D, Winkel A, Hamm B, Lenk S, Loening SA, Taupitz MM,. R imaging-guided prostate biopsy with a closed MR unit at 1.5 T: initial results. Radiology 2005; 234: 576-581
12. Pondman KM, Fütterer JJ, ten Haken B, et-al. MR-guided biopsy of the prostate: an overview of techniques and a systematic review. Eur Urol 2008; 54: 517-527
13. Xu S, Kruecker J, Turkbey B, et-al. Real-time MRI-TRUS fusion for guidance of targeted prostate biopsies. Comput Aided Surg 2008; 13: 255-264
14. Pinto PA, Chung PH, Rastinehad AR, et-al. Magnetic resonance imaging/ultrasound fusion guided prostate biopsy improves cancer detection following transrectal ultrasound biopsy and correlates with multiparametric magnetic resonance imaging. J Urol 2011; 186: 1281-1285
15. Sonn GA, Natarajan S, Margolis DJ, et-al. Targeted biopsy in the detection of prostate cancer using an office based magnetic resonance ultrasound fusion device. J Urol 2013; 189: 86-91
16. Walton Diaz A, Hoang AN, Turkbey B, et-al. Can magnetic resonance-ultrasound fusion biopsy improve cancer detection in enlarged prostates? J Urol 2013; 190: 2020-2025
17. Vourganti S, Rastinehad A, Yerram NK, et-al. Multiparametric magnetic resonance imaging and ultrasound fusion biopsy detect prostate cancer in patients with prior negative transrectal ultrasound biopsies. J Urol 2012; 188: 2152-2157
18. Siddiqui MM, Rais-Bahrami S, Truong H, et-al. Magnetic resonance imaging/ultrasound-fusion biopsy significantly upgrades prostate cancer versus systematic 12-core transrectal ultrasound biopsy. Eur Urol 2013; 64: 713-719
19. Logan JK, Rais-Bahrami S, Turkbey B, et-al. Current status of magnetic resonance imaging (MRI) and ultrasonography fusion software platforms for guidance of prostate biopsies. BJU Int 2014; 114: 641-652
20. Moore CM, Robertson NL, Arsanious N, et-al. Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review. Eur Urol 2013; 63: 125-140
21. Hong CW, Amalou H, Xu S, et-al. Prostate biopsy for the interventional radiologist. J Vasc Interv Radiol 2014; 25: 675-684
22. Turkbey B, Mani H, Aras O, et-al. Correlation of magnetic resonance imaging tumor volume with histopathology. J Urol 2012; 188: 1157-1163
23. Turkbey B, Pinto PA, Mani H, et-al. Prostate cancer: value of multiparametric MR imaging at 3 T for detection-histopathologic correlation. Radiology 2010; 255: 89-99
24. Rais-Bahrami S, Türkbey B, Rastinehad AR, et-al. Natural history of small index lesions suspicious for prostate cancer on multiparametric MRI: recommendations for interval imaging follow-up. Diagn Interv Radiol 2014; 20: 293-298
25. Uzzo RG, Wei JT, Waldbaum RS, Perlmutter AP, Byrne JC, Vaughan ED Jr,. The influence of prostate size on cancer detection. Urology 1995; 46: 831-836
26. Ung JO, San Francisco IF, Regan MM, DeWolf WC, Olumi AF,. The relationship of prostate gland volume to extended needle biopsy on prostate cancer detection. J Urol 2003; 169: 130-135
27. Karakiewicz PI, Bazinet M, Aprikian AG, et-al. Outcome of sextant biopsy according to gland volume. Urology 1997; 49: 55-59
28. Hong CW, Walton-Diaz A, Rais-Bahrami S, et-al. Imaging and pathology findings after an initial negative MRI-US fusion-guided and 12-core extended sextant prostate biopsy session. Diagn Interv Radiol 2014; 20: 234-238
29. Stamatakis L, Siddiqui MM, Nix JW, et-al. Accuracy of multiparametric magnetic resonance imaging in confirming eligibility for active surveillance for men with prostate cancer. Cancer 2013; 119: 3359-3366